Published in Laryngoscope on December 03, 2012
Robot-assisted selective neck dissection combined with facelift parotidectomy in parotid cancer. Head Neck (2014) 0.81
Endoscopic-assisted selective neck dissection via small lateral neck incision for early-stage (T1-2N0M0) head and neck squamous cell carcinoma: 3-year follow-up results. Surg Endosc (2016) 0.77
Minimally Invasive Neck Dissection (MIND) Using Standard Laparoscopic Equipment: a Preliminary Report and Description of Technique. Indian J Surg Oncol (2015) 0.75
Systematic identification of genomic markers of drug sensitivity in cancer cells. Nature (2012) 15.91
An ATP-competitive mammalian target of rapamycin inhibitor reveals rapamycin-resistant functions of mTORC1. J Biol Chem (2009) 12.73
Correlations of oral tongue cancer invasion with matrix metalloproteinases (MMPs) and vascular endothelial growth factor (VEGF) expression. J Surg Oncol (2006) 1.86
HPV integration begins in the tonsillar crypt and leads to the alteration of p16, EGFR and c-myc during tumor formation. Int J Cancer (2007) 1.80
Monoacylglycerol lipase exerts dual control over endocannabinoid and fatty acid pathways to support prostate cancer. Chem Biol (2011) 1.74
Golgicide A reveals essential roles for GBF1 in Golgi assembly and function. Nat Chem Biol (2009) 1.65
Sonographically guided fine-needle aspiration biopsy of major salivary gland masses: a review of 245 cases. AJR Am J Roentgenol (2011) 1.55
Is human papillomavirus a causative factor of glottic cancer? J Voice (2011) 1.51
Utility of injection laryngoplasty in the management of post-thyroidectomy vocal cord paralysis. Thyroid (2010) 1.50
The efficacy of the harmonic scalpel in neck dissection: a prospective randomized study. Laryngoscope (2012) 1.44
Feasibility of robot-assisted submandibular gland resection via retroauricular approach: preliminary results. Laryngoscope (2012) 1.42
Predictive factors for ipsilateral or contralateral central lymph node metastasis in unilateral papillary thyroid carcinoma. Ann Surg (2009) 1.33
Surgical treatment of carotid body paragangliomas: outcomes and complications according to the shamblin classification. Clin Exp Otorhinolaryngol (2010) 1.27
Confirming target engagement for reversible inhibitors in vivo by kinetically tuned activity-based probes. J Am Chem Soc (2012) 1.24
Chondrosarcoma of the head and neck. Yonsei Med J (2005) 1.22
Risk factors and dose-effect relationship for mandibular osteoradionecrosis in oral and oropharyngeal cancer patients. Int J Radiat Oncol Biol Phys (2009) 1.20
The harmonic scalpel technique without supplementary ligation in total thyroidectomy with central neck dissection: a prospective randomized study. Ann Surg (2008) 1.16
Treatment of an acute salivary fistula after parotid surgery: botulinum toxin type A injection as primary treatment. Eur Arch Otorhinolaryngol (2007) 1.15
Is lack of placement of drains after thyroidectomy with central neck dissection safe? A prospective, randomized study. Laryngoscope (2006) 1.14
(-)-Epigallocatechin-3-gallate (EGCG) inhibits HGF-induced invasion and metastasis in hypopharyngeal carcinoma cells. Cancer Lett (2008) 1.14
Current clinical propensity of laryngeal tuberculosis: review of 60 cases. Eur Arch Otorhinolaryngol (2006) 1.08
Treatment of contralateral N0 neck in early squamous cell carcinoma of the oral tongue: elective neck dissection versus observation. Laryngoscope (2006) 1.07
Nasopharyngectomy for recurrent nasopharyngeal cancer: a 2- to 17-year follow-up. Arch Otolaryngol Head Neck Surg (2002) 1.07
Prevalence of otolaryngologic diseases in South Korea: data from the Korea national health and nutrition examination survey 2008. Clin Exp Otorhinolaryngol (2010) 1.06
Epidemiologic survey of head and neck cancers in Korea. J Korean Med Sci (2003) 1.05
Tissue-engineered tracheal reconstruction using three-dimensionally printed artificial tracheal graft: preliminary report. Artif Organs (2014) 1.03
Transoral robotic surgery (TORS) in laryngeal and hypopharyngeal cancer. J Laparoendosc Adv Surg Tech A (2009) 1.03
Recurrence and salvage treatment of squamous cell carcinoma of the oral cavity. Oral Oncol (2006) 1.01
All-trans-retinoic acid inhibits growth of head and neck cancer stem cells by suppression of Wnt/β-catenin pathway. Eur J Cancer (2012) 0.98
Transoral robotic surgery for neurogenic tumors of the prestyloid parapharyngeal space. Auris Nasus Larynx (2012) 0.98
Weekly docetaxel in patients with platinum-refractory metastatic or recurrent squamous cell carcinoma of the head and neck. Cancer Chemother Pharmacol (2009) 0.97
Robot-assisted Supraomohyoid neck dissection via a modified face-lift or retroauricular approach in early-stage cN0 squamous cell carcinoma of the oral cavity: a comparative study with conventional technique. Ann Surg Oncol (2012) 0.97
The predictors of poorly controlled asthma in elderly. Allergy Asthma Immunol Res (2012) 0.96
Evaluation of NHS carbamates as a potent and selective class of endocannabinoid hydrolase inhibitors. ACS Chem Neurosci (2013) 0.96
Expression of hepatocyte growth factor and c-Met in hypopharyngeal squamous cell carcinoma. Acta Otolaryngol (2006) 0.96
Discovery and optimization of piperidyl-1,2,3-triazole ureas as potent, selective, and in vivo-active inhibitors of α/β-hydrolase domain containing 6 (ABHD6). J Med Chem (2013) 0.96
c-Met expression as an indicator of survival outcome in patients with oral tongue carcinoma. Head Neck (2010) 0.95
Clipless and sutureless endoscopic thyroidectomy using only the harmonic scalpel. Surg Endosc (2009) 0.94
Comparative Analysis of Efficiency of Injection Laryngoplasty Technique for with or without Neck Treatment Patients: A Transcartilaginous Approach Versus the Cricothyroid Approach. Clin Exp Otorhinolaryngol (2010) 0.94
Management of contralateral N0 neck in pyriform sinus carcinoma. Laryngoscope (2006) 0.93
A novel fluorophosphonate inhibitor of the biosynthesis of the endocannabinoid 2-arachidonoylglycerol with potential anti-obesity effects. Br J Pharmacol (2013) 0.92
Preserving level IIb lymph nodes in elective supraomohyoid neck dissection for oral cavity squamous cell carcinoma. Arch Otolaryngol Head Neck Surg (2004) 0.91
An agonistic antibody to human death receptor 4 induces apoptotic cell death in head and neck cancer cells through mitochondrial ROS generation. Cancer Lett (2012) 0.91
Giant cell tumor of the mandible. Clin Exp Otorhinolaryngol (2011) 0.91
Endoscopic supraomohyoid neck dissection via a retroauricular or modified facelift approach: preliminary results. Head Neck (2013) 0.91
Management of contralateral N0 neck in oral cavity squamous cell carcinoma. Head Neck (2006) 0.91
Distributions of cervical lymph node metastases in oropharyngeal carcinoma: therapeutic implications for the N0 neck. Laryngoscope (2006) 0.90
Clinical outcomes for T1-2N0-1 oral tongue cancer patients underwent surgery with and without postoperative radiotherapy. Radiat Oncol (2010) 0.90
Tolfenamic acid induces apoptosis and growth inhibition in head and neck cancer: involvement of NAG-1 expression. PLoS One (2012) 0.90
Management of contralateral N0 neck in tonsillar squamous cell carcinoma. Laryngoscope (2005) 0.89
Metastasis to the submandibular gland in oral cavity squamous cell carcinomas: pathologic analysis. Acta Otolaryngol (2009) 0.89
Robot-assisted selective neck dissection of levels II to V via a modified facelift or retroauricular approach. Otolaryngol Head Neck Surg (2013) 0.89
Growth inhibition and apoptosis by (-)-epicatechin gallate are mediated by cyclin D1 suppression in head and neck squamous carcinoma cells. Eur J Cancer (2006) 0.89
Adult asthma biomarkers. Curr Opin Allergy Clin Immunol (2014) 0.89
Predictive factors of level IIb lymph node metastasis in patients with papillary thyroid carcinoma. Ann Surg Oncol (2009) 0.88
Prediction of hypothyroidism after hemithyroidectomy: a biochemical and pathological analysis. Eur Arch Otorhinolaryngol (2007) 0.88
Feasibility of transoral lateral oropharyngectomy using a robotic surgical system for tonsillar cancer. Oral Oncol (2009) 0.88
Correlation of neotongue volume changes with functional outcomes after long-term follow-up of total glossectomy. J Craniofac Surg (2010) 0.88
Expression of NSAID-activated gene-1 by EGCG in head and neck cancer: involvement of ATM-dependent p53 expression. J Nutr Biochem (2012) 0.87
Selective inhibitor of platelet-activating factor acetylhydrolases 1b2 and 1b3 that impairs cancer cell survival. ACS Chem Biol (2015) 0.87
Overexpression of c-Met promotes invasion and metastasis of small oral tongue carcinoma. Oral Oncol (2012) 0.86
Level V lymph node dissection in oral and oropharyngeal carcinoma patients with clinically node-positive neck: is it absolutely necessary? Laryngoscope (2006) 0.86
Feasibility of robot-assisted neck dissections via a transaxillary and retroauricular ("TARA") approach in head and neck cancer: preliminary results. Ann Surg Oncol (2011) 0.86
Radioprotective effect of epicatechin in cultured human fibroblasts and zebrafish. J Radiat Res (2013) 0.86
Comparison study of transoral robotic surgery and radical open surgery for hypopharyngeal cancer. Acta Otolaryngol (2013) 0.86
The extended indication of parotidectomy using the modified facelift incision in benign lesions: retrospective analysis of a single institution. World J Surg (2011) 0.86
Radial forearm-palmaris longus tenocutaneous free flap; implication in the repair of the moderate-sized postoncologic soft palate defect. Head Neck (2009) 0.86
Prophylactic lymphadenectomy of neck level II in clinically node-positive papillary thyroid carcinoma. Ann Surg Oncol (2010) 0.85
Is dissection of level IV absolutely necessary in elective lateral neck dissection for clinically N0 laryngeal carcinoma? Oral Oncol (2005) 0.85
IL-5 Promoter Polymorphism Enhances IgE Responses to Staphylococcal Superantigens in Adult Asthmatics. Allergy Asthma Immunol Res (2012) 0.85
Expression of matrix metalloproteinases and their inhibitors in squamous cell carcinoma of the tonsil and their clinical significance. Clin Exp Otorhinolaryngol (2011) 0.85
Occult lymph node metastases in neck level V in papillary thyroid carcinoma. Surgery (2009) 0.85
Robotic total thyroidectomy with modified radical neck dissection via unilateral retroauricular approach. Ann Surg Oncol (2014) 0.84
Change of E-cadherin by hepatocyte growth factor and effects on the prognosis of hypopharyngeal carcinoma. Ann Surg Oncol (2007) 0.84
Dermatomyositis developing in the first trimester of pregnancy. Korean J Intern Med (2003) 0.84
Conservative parotidectomy for the treatment of parotid cancers. Oral Oncol (2005) 0.84
Surgery alone for squamous cell carcinoma of the oral cavity: survival rates, recurrence patterns, and salvage treatment. Acta Otolaryngol (2008) 0.84
Effect of decannulation on pharyngeal and laryngeal movement in post-stroke tracheostomized patients. Ann Rehabil Med (2012) 0.84
Comparison of oncologic and functional outcomes after transoral robotic lateral oropharyngectomy versus conventional surgery for T1 to T3 tonsillar cancer. Head Neck (2013) 0.83
Occult contralateral central lymph node metastases in papillary thyroid carcinoma with unilateral lymph node metastasis in the lateral neck. J Am Coll Surg (2010) 0.83
Robot-assisted selective neck dissection via modified face-lift approach for early oral tongue cancer: a video demonstration. Ann Surg Oncol (2011) 0.83
Level IIb lymph node metastasis in laryngeal squamous cell carcinoma. Laryngoscope (2006) 0.83
Endoscopic resection of upper neck masses via retroauricular approach is feasible with excellent cosmetic outcomes. J Oral Maxillofac Surg (2012) 0.82
Nineteen-year oncologic outcomes and the benefit of elective neck dissection in salivary gland adenoid cystic carcinoma. Head Neck (2014) 0.82